Transgenic Mouse Model for Site-Specific Protein Modification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to temporally and spatially control site-specific modification of target proteins in mice, limiting detailed in vivo studies of protein functions and their roles in human diseases.

Innovation Solution

A transgenic mouse model is developed by introducing a tRNA synthetase specific for an unnatural amino acid, a tRNA that recognizes this amino acid, and a gene encoding a target protein with an amber codon, allowing for temporal and spatial control of site-specific protein modification through the incorporation of unnatural amino acids.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If the amber codon suppression technique is used to enable site-specific modification of proteins, then protein functionality can be expanded at the molecular and cellular level, but the technique has not been successfully extended to multiorgan animal mice

Engineering Contradiction:
Improveprotein functionalityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention divides the complex system into separate transgenic components: (1) a first transgene encoding an orthogonal aminoacyl-tRNA synthetase and tRNA for amber codon suppression, and (2) a second transgene encoding the target protein with amber codons at specific positions. This segmentation allows each component to be optimized independently and combined in mice, resolving the complexity barrier while maintaining protein functionality expansion capability.

Inventive Principle:
Principle #1Segmentation

2Reliability

If conventional methods are used for studying protein functions in mice, then general protein expression can be achieved, but temporal and spatial control of site-specific modification is not possible

Engineering Contradiction:
Improvein vivo study reliabilityVSAvoidcontrol capability
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention introduces an intermediary control mechanism using unnatural amino acids (e.g., acetyl-lysine analogs) that serve as mediators between the researcher and the target protein. By feeding or injecting these small molecule intermediaries, researchers can temporally and spatially control the incorporation of modified amino acids into target proteins at amber codon sites, enabling precise control while maintaining reliable in vivo study conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If site-specific protein modification is achieved without temporal and spatial control, then protein diversity can be expanded, but detailed in vivo studies of protein functions remain limited

Engineering Contradiction:
Improveprotein diversityVSAvoidspatial and temporal information
Core Design Contradiction:
Adaptability or versatilityVSLoss of information

Solution Approach 1:

The invention performs preliminary action by pre-installing amber codons at specific positions in the target protein gene sequence before expression in mice. This preliminary genetic modification creates predetermined sites where site-specific modification can occur, allowing researchers to later control when and where modifications happen by introducing unnatural amino acids, thereby preserving spatial and temporal information that would otherwise be lost.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise temporal and spatial control of protein expression and modification in mice, facilitating in vivo studies of protein functions and their roles in human diseases, including cancer and neurodegenerative disorders.

Implementation Method 1

a tRNA synthetase specific for an unnatural amino acid

Methodology Applied
Scientific EffectEnzyme: Enzyme

Data Source

PatentUS10905107B2Transgenic mouse capable of spatial and temporal control of expression and site-specific modification of target protein, production method and uses thereof
Publication Date: 2021.02.02 KOREA ADVANCED INST OF SCI & TECH
  • US10905107B2 patent drawing
  • US10905107B2 patent drawing
  • US10905107B2 patent drawing

AI summary

The present invention relates to a mouse (Mus musculus) in which expression and site-specific modification of a target protein is temporally and spatially controlled, and a method for producing the same and the use thereof, and more particularly to a transgenic mouse in which expression of a target protein having a modification attached to a specific position is temporally and spatially controlled as a result of incorporation of an unnatural amino acid. In the mouse according to the present invention, in which site-specific modification of a target protein is temporally and spatially controllable, expression of the target protein having the site-specific modification attached thereto is controllable depending on the timing and/or position of introduction of an unnatural amino acid. Thus, the mouse according to the present invention is useful for studies on the in vivo functions of cellular proteins, various human diseases including cancers and neurodegenerative disorders, new drug discovery, and the like.